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In a recent paper, Nagpal et al. [1] voiced concerns about the limited or biased use of scientific
evidence to support public health interventions to control neglected tropical diseases (NTDs).
Visceral leishmaniasis (VL), also known as kala-azar, is one of the major NTDs and does not
escape this problem. Transmission is vector-borne and the Indian subcontinent is the region
reporting most of the VL cases worldwide. In this region, the main causative species is Leish-
mania donovani and Phlebotomus argentipes is the vector. Transmission is considered anthro-
ponotic and peridomestic—occurring at night when female sand flies bite people sleeping
inside their house. The World Health Organization and the governments of India, Nepal, and
Bangladesh set out in 2005 to eliminate VL from the region by 2015 through a combination of
early treatment of cases and vector control. However, while recent advances in diagnostic tools
and drugs have significantly improved case management strategies, the available vector control
tools against P. argentipes remain limited. The elimination initiative promotes the use of indoor
residual spraying (IRS) of households and cattle sheds to reduce vector density, but the evi-
dence underpinning the effectiveness of IRS in this region is scanty. Historical observations
show that L. donovani transmission declined concomitantly with dichlorodiphenyltrichlor-
oethane (DDT) spraying during the 1950s–60s to eradicate malaria. In the aftermath of this
malaria eradication campaign, very few VL cases were observed in endemic regions until the
mid-seventies, when there was resurgence of a VL epidemic in India [2]. To date, there are no
randomized trials showing the effect of IRS on the incidence of clinical VL [3,4], though some
studies showed a reduction in vector density. When the VL elimination initiative was launched
in 2005, there were no clear alternatives for IRS as a vector control strategy. Insecticide treated
nets (ITNs) were proposed as an alternative or complement to IRS on the basis of analogy
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arguments regarding their given efficacy against malaria [5] or on data from observational
studies suggesting ITNs reduce the risk of VL [2]; but as for IRS, there were no randomized tri-
als evaluating the effect of ITNs on L. donovani transmission. In this context, a number of field
studies were conducted in the Indian subcontinent in the past decade to evaluate the effective-
ness and impact of ITNs and other vector control tools on VL. Most of these studies have been
reviewed in detail in two recent papers [3,4]. The only two studies evaluating the impact of vec-
tor control interventions on clinical outcomes found conflicting results. First, the KALANET
project, a cluster randomised controlled trial (CRT) in India and Nepal, showed that mass-
distribution of ITNs did not reduce the risk of L. donovani infection or clinical VL [6]. Then,
an intervention trial in Bangladesh suggested that widespread bed net impregnation with slow-
release insecticide may reduce the frequency of VL [7]. Technical (e.g., type of nets and insecti-
cides, lack of replicas and randomisation in Bangladesh) and biological factors (e.g., insecticide
susceptibility and sand fly behaviour) may explain the different results observed. This apparent
contradiction raises the question about the role that ITN may play in controlling VL in the In-
dian subcontinent but has also triggered a lot of discussion on methodology and evidence levels
required when evaluating vector control tools for VL. In this paper, we would like to summa-
rise the lessons learned from the KALANET CRT in terms of methodology to inform the gen-
eration of future evidence and discuss interpretation of findings against this background.
The KALANET trial was designed to evaluate the distribution of ITNs as a public health in-
tervention to prevent VL in the Indian subcontinent. The objective was to answer the question:
“in the current context in India and Nepal, would free mass distribution of ITN significantly re-
duce the incidence rate of VL in endemic regions?” This was a question asked not at the indi-
vidual level, whether sleeping under an ITNs protects an individual against VL compared to an
individual not sleeping under an ITN, but a question asked at program level: does such preven-
tion measure reduce VL incidence in communities. Furthermore, the question was about effec-
tiveness in real life conditions and not a question about efficacy of ITNs in “laboratory
conditions,” a difference that is clear for public health experts but not necessarily for all readers.
The answer to this question may, for instance, be entirely different in a country such as Bangla-
desh, where no vector control program was operating for many years, no spraying was imple-
mented at the time, and fewer households were using untreated nets, compared to India and
Nepal. The first lesson we learned was about the importance of clarifying the research
question itself.
To answer the above question, we adopted a study design used previously in a successful in-
tervention trial on zoonotic VL transmission [8]. We designed a CRT to demonstrate a 50% re-
duction on the risk of L. donovani infection associated to the village-wide distribution of ITN
[6]. Long-lasting insecticidal nets (LNs) were chosen as intervention as they remain effective
for three to four years in the field [2]. Incident L. donovani infection, measured as seroconver-
sion in the Direct Agglutination Test (DAT), was used as the main outcome. Measuring the im-
pact of LN on the risk of clinical VL would have been the preferred primary outcome, but its
low incidence and the long incubation period precluded this. Incidence of VL cases was none-
theless measured as secondary outcome. The trial was conducted in 26 high-incidence clusters
(16 in India and 10 in Nepal) with over 20,000 inhabitants followed over 24 months. After ran-
domisation, LNs were distributed in all households in the 13 intervention clusters, with the
number of LNs proportional to household size, to make sure that all household members could
sleep under the nets. Participants in the control clusters were allowed to continue using their
untreated nets. The effect of LNs on the incidence rate of seroconversion and VL was compared
after 24 months between intervention and control clusters. No LNs were used in the control
clusters. The results of the trial, analysed as suggested by Hayes and Moulton [9], showed that
the large scale distribution of LN did not reduce the risk of L. donovani infection [6]. These
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results were consistent across several endpoints measured, as no difference was observed in (1)
incidence rate of clinical VL [6], (2) seroconversion in rK39 ELISA (a second serological mark-
er) [10], and (3) mean P. argentipes exposure measured at cluster level by a sand fly saliva anti-
body detection ELISA [11]. Similarly, the reduction of P. argentipes density indoor in the study
clusters was limited (24.9%) [12]. The main conclusion of the trial was that “there is no evi-
dence that using LNs as a public health intervention provides additional protection against VL
at community level compared with existing control practices in India and Nepal (e.g., irregular
use of untreated nets and IRS). This does not mean that the use of LNs in those VL endemic re-
gions should be dismissed, as they may provide some degree of personal protection against
sand flies [13] and have been shown to reduce the risk of malaria [6]. However, the VL elimina-
tion initiative in India and Nepal cannot rely on the stand-alone use of LNs to effectively con-
trol transmission.”
The above message is complex and was disappointing for many, in the first place for the re-
searchers themselves, as the hopes for a user-friendly, household-controlled tool to control VL
in the Indian subcontinent were given a serious blow. Moreover, results from a negative trial
are hard to communicate. Criticism of peers focused on four main areas: 1. the biological ratio-
nale for the intervention, 2. the choice and number of units of analysis, 3. the choice of end-
point and 4. the adherence to the intervention. Stockdale and Newton also identified these
methodological issues as key factors to evaluate studies testing preventative methods against
human leishmaniasis infection [3].
Rationale for the Intervention
In theory, LNs could be an effective tool to prevent L. donovani transmission, as P. argentipes
are supposed to bite people indoors while they sleep [14]. However, recent entomological find-
ings in India indicate that L. donovani vectors are more exophilic and exophagic than previous-
ly reported [15,16]. If P. argentipes bite people outdoors (e.g., in the early evening when and
where bed nets are not deployed), LNs will have a limited impact on L. donovani transmission.
Moreover, as P. argentipes is also zoophagic [17], LNs will have a limited impact on vector sur-
vival and thus on transmission [18]. We hypothesised that these were the main factors explain-
ing the KALANET trial results as participants used the mosquito nets correctly (see below);
vectors were susceptible to the insecticide used in the nets (e.g., deltamethrin [19]), and LNs
provide an effective barrier effect against P. argentipes [20]. Unfortunately, the KALANET trial
was not designed to study P. argentipes behaviour. For example, the effect of LNs on vector
density was only measured indoors [21]. Entomological studies are urgently required to docu-
ment the transmission dynamics of L. donovani in the Indian subcontinent.
The Unit of Analysis
In KALANET, the unit of analysis was a cluster with 350 to 1,500 people corresponding to a
hamlet (“tola” in India, “ward” in Nepal). These clusters were selected based on their previous
history of VL: at least one VL case in the last three years and minimum VL incidence of 0.8%
during that period. Clusters were pair-matched based on their prior VL incidence. The number
of clusters was calculated assuming a 2% yearly L. donovani infection incidence rate and a coef-
ficient of variation between clusters (κ) of 0.25 [6]. It is known that VL cases are clustered in
space and time. VL cases tend to occur in microepidemics, affecting one village, lasting three to
five years, fading out only to reappear in another area. This phenomenon is supposed to be re-
lated, among other factors, to herd immunity at village level. The criteria used to select the clus-
ters in the KALANET study may have resulted in a variety of villages at different stages in
those “microepidemic cycles,” with some villages still on the increasing slope of the incidence
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curve and others on the decrease. This did not invalidate the study design or trial outcomes, as
clusters were randomly allocated to both study arms. However, the inclusion of some clusters
in the late phases of the local epidemic may have decreased the power of the study as more inci-
dent infections and VL cases are expected in a more “naïve” population. Future trial designs
should take this into account and try to include clusters as early in the cycle as possible. Sample
size calculations at design stage were based on an expected L. donovani infection incidence of
2% which proved correct—but we underestimated the clustering of incident infections as the
observed coefficient of variation for L. donovani infection was 0.56 instead of 0.25. This ob-
served k-value may be of use for the planning of future intervention trials. In the KALANET
trial, we increased the number of clusters by 30% (13 clusters per arm instead of 10 initially
planned) to increase the power of the study.
The Endpoint
Using VL cases as the primary outcome for a community intervention trial, instead of L. dono-
vani infection, is the better option. However, this would have necessitated a much larger num-
ber of clusters, and the low VL incidence may result in clusters having low counts (e.g., less
than five VL cases). We therefore considered several L. donovani infection markers as alterna-
tives. Seroconversion in the DAT test is strongly associated with clinical VL [22,23]. We chose
it as the main outcome of the KALANET trial based on results from previous VL trials [8].
rK39 ELISA, used as a secondary serological marker, showed poor agreement with DAT [24]
and presented different kinetics in past VL cases compared to DAT [25]. High rK39 titres are
equally associated with progression to clinical disease [22]. The Leishmanin Skin Test (LST),
initially postulated as an alternative or complement to serological tests, was discarded because
of problems from a source good manufacturing practices (GMP)-manufactured antigen and
some erratic results observed in the study area [26]. As stated above, analysis of all endpoints
in KALANET gave consistent results.
Adherence to the Intervention
From the start of the study project, we included a large research component on “acceptability”
of the intervention, using mixed methods, including Knowledge-Attitude-Practices surveys,
observation, and focus group discussions. The acceptability of bed nets was a priori not consid-
ered problematic in this region as bed net coverage and use is high in rural villages in the Indi-
an subcontinent [7,27,28]. People like to protect themselves from insect nuisance at night by
sleeping under nets, as it enhances quality of sleep. This pattern is season dependent though,
with less use in the hotter months. The availability of commercial bed nets in the communities
living in the KALANET clusters was widespread before we started the trial: 70% to 80% of
households in Nepal and India had at least one net at baseline [6]. Those nets were all untreat-
ed, many were damaged, and most of the families did not have enough nets to protect all
household members. Nevertheless, untreated mosquito nets were commonplace in the study
villages and most households used untreated nets [27,28].
However, even if communities in the study area were familiar with the use of bed nets, we
conducted a series of activities to ensure the correct and regular use of LNs distributed in inter-
vention clusters. First, we selected from the available LN brands the product that best met the
people’s preference based on a formal comparative evaluation of several brands [29], and we
took into account cultural preferences regarding colour and size of the nets. Enough LNs were
provided per household to ensure all family members could sleep under a treated net while at
the same time respecting existing sleeping patterns. We did not take away the existing commer-
cial nets in the control clusters, but did so in the intervention clusters, in exchange for the new
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LNs. It is important to remember that untreated nets were already in use before the trial with
no apparent effect on L. donovani transmission in those VL endemic communities. Forbidding
the use of untreated nets in control clusters would have been unethical.
To enhance the correct use of LNs, field workers organised meetings in the villages and dis-
tributed Information-Education-Communication (IEC) materials (e.g., pictorial diagrams in
local language) to promote the correct use (e.g., net deployment, washing frequency) of the
LNs. The content of these IEC messages was largely inspired from prior findings in focus
group discussions on perception of the disease and attitudes with regard to preventive mea-
sures. Finally, quarterly house-to-house surveys were conducted during the trial to monitor
and promote the regular use of LN in the intervention clusters. So by the end of the trial, the
use of LNs in intervention clusters was very high: 91% of the individuals in those clusters slept
more than 80% of the nights under a treated net [6]. This figure contrasts with the 30% of peo-
ple in control clusters, where no LNs were distributed, who reported regular use of their un-
treated nets during the trial [6]. Some peer reviewers argued that the use of untreated nets in
control clusters may have masked the possible effect of LNs in VL incidence, and this is correct
to a certain extent, but cannot have led to a huge impact given their low, irregular, and
inconsistent use.
The KALANET study was a huge collaborative endeavour of seven research teams in six
countries, conducted at a marginal cost of 2 million €, a budget provided by the 6th Framework
Programme of the European Union (INCO/RTD). One can ask whether this huge research ef-
fort is (a) required to underpin public health policy and (b) cost-effective?
We think that this level of evidence from properly conducted randomized controlled trials
testing effects on human morbidity and mortality is indeed required before adopting novel vec-
tor control tools as public health policy, as effects on vector density only are not sufficient to
demonstrate health impact. A randomized controlled design over a sufficient number of study
units is required in this highly variable and hyper-clustered disease. CRTs remain the preferred
design to evaluate public health interventions at community level.
Whether these large research projects are also “cost-effective” or value for money is not easy
to answer, as the opportunity cost of ineffective health policy should be put in the balance.
Moreover, the benefits of a CRT are often not limited to a single outcome measure. The KALA-
NET study allowed us to better understand the epidemiology of VL in India and Nepal, and the
data generated were used to develop a mathematical model evaluating the L. donovani trans-
mission parameters and control measures against VL in the Indian subcontinent [30,31]. This
transmission model suggests that integrated vector management (e.g., combining IRS and
LNs) is the best approach to overcome the limitations of the current vector control strategy
[31]. Mathematical modelling can help designing new vector control methods that then need
to be evaluated in the field. The KALANET project not only highlighted the huge need for in-
novation in vector control in VL, but pointed also to the fundamental knowledge gaps in this
domain. Better understanding of the vector bionomics (e.g., biting rhythm, population dynam-
ics, endophagy and exophagy, and endophily and exophily) and human behaviour (e.g., sleep-
ing habits) is essential to develop new control measures.
Nonetheless, if we want to foster innovation in vector control, we should scrutinize and sim-
plify the evaluation methodology of new vector control tools for VL, as the huge resources and
time required for the comprehensive evaluation approach adopted in the KALANET project
cannot be mainstreamed for every single study. As for drugs and diagnostics, a “pipeline ap-
proach” to the development of new vector control interventions, with proof of principle leading
to evaluation in several staged design phases (I, II, III, and IV), should be promoted [32]. Alter-
native methods for a quick evaluation of the entomological efficacy of new P. argentipes control
tools under field conditions are needed [13]. An individual marker of P. argentipes exposure as
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a sand fly saliva antibody test—if validated—could allow the direct evaluation of vector control
measures. For the last stage of the pipeline, the impact evaluation, alternative CRT designs
(e.g., crossover or stepped wedge designs) and sample size calculation methods should be ex-
plored to take into account the spatiotemporal clustering of rare events. We also suggest select-
ing clusters in the early stages of the local epidemic cycle and using a higher k-value (e.g., 0.50)
for sample size calculation as well as analysis. The use of new end points to measure the impact
of those interventions at population level in a more efficient way would make a difference [33].
New and better markers of L. donovani infection (e.g., cellular immunity markers) should be
developed and evaluated.
In conclusion, the KALANET trial is thus far the only CRT evaluating the impact of ITN on
VL. The CRT design should be taken into account when the KALANET results are evaluated
and compared to other studies using a less robust methodology (e.g., a nonrandomized trial
comparing two clusters, one area with bed net impregnation and one without in Bangladesh
[7]). In the context of VL in the Indian subcontinent, entomological and epidemiological stud-
ies should be conducted to better understand L. donovani transmission in endemic villages.
IRS, which remains the main vector control strategy in the region, needs to be reassessed, and
integrated vector methods (e.g., IRS combined with LNs) should be evaluated using a CRT de-
sign. Finally, a randomized controlled design is essential to produce evidence for health policy
in this field, and methodological innovation is urgently needed to make the Research & Devel-
opment (R&D) pipeline process more efficient.
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